Skip to main content

Compugen Ltd

CGEN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001119774

In the last 90 days, Compugen Ltd insiders filed 0 open-market purchases and 1 sale; 83 institutions reported holding it in 13F filings for Q2 2026, worth $30.3M in total; ARK Invest is the only superinvestor holding it.

Q1 2026 vs. Q4 2025

How the institutions holding Compugen Ltd changed between Q4 2025 and Q1 2026.

All holders in Q1 2026All holders in Q4 2025

13F holders of CGEN: Q4 2025 compared with Q1 2026
MeasureQ4 2025Q1 2026Change
Holders7379+6
Shares12.6M14.2M+1.60M (+12.6%)
Value$19.3M$30.3M+$11.0M (+56.8%)

New holders (13)

Institutions that held Compugen Ltd at the end of Q1 2026 but not at the end of Q4 2025.

Institutions new to CGEN in Q1 2026
InstitutionSharesValue% of portfolio
ARK Investment Management LLCSuperinvestorARK Invest1,049,873$2.24M0.02%
Millennium Management LLC168,927$359.8K0.00%
SRS Capital Advisors, Inc.131,800$280.7K0.01%
Cresset Asset Management, LLC111,079$236.6K0.00%
SIH Partners, LLLP46,831$99.8K0.00%
Sullivan Wood Capital Management LLC35,000$74.5K0.13%
Hillsdale Investment Management Inc.31,730$67.6K0.00%
Calamos Advisors LLC29,500$62.8K0.00%
Axq Capital, LP26,747$57.0K0.01%
Magnolia Capital Advisors LLC25,000$53.3K0.01%
HRT Financial LP25,163$53.0K0.00%
Qube Research & Technologies Ltd12,197$26.0K0.00%
Caitong International Asset Management Co., Ltd2$40.00%

Sold out (7)

Institutions that held Compugen Ltd at the end of Q4 2025 and filed for Q1 2026 without it.

Institutions that sold out of CGEN in Q1 2026
InstitutionShares, Q4 2025Value, Q4 2025
Two Sigma Advisers, LP248,884$380.8K
Citigroup Inc13,471$20.6K
Cambridge Investment Research Advisors, Inc.11,250$17.0K
Wealth Enhancement Advisory Services, LLC10,313$16.0K
Bank of America Corp8,580$13.1K
Eastern Bank2,000$3.06K
Essential Partners LLC146$223